Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent"), a technology-based company with a well-established laboratory services ...

Vyriad, Inc., a clinical-stage biotechnology company developing targeted genetic therapies for cancer and other serious diseases, today announced the closing of the $25M final tranche to its Series B ...

If it were not for the decision of the Council of Europe, international law would no longer exist — Ukrinform.

Studienergebnisse DiNAQOR and Academic Partners Launch Paradigm Shift in In Vivo Delivery of Advanced Therapies 23.12.2025 / 14:36 CET/CEST ...

VIA Labs' industrial-grade USB 2.0 hub controllers are engineered for stable and reliable operation in extended-temperature ...

VIA Labs, Inc. (VLI), a leading supplier of USB4, SuperSpeed USB, USB 2.0, and USB Power Delivery Controllers, announced its ...

Through a recent notice, the Undergraduate Medical Education Board (UGMEB) of the National Medical Commission (NMC) has ...

Phoenix Contact, Softing and Mitsubishi/Iconics show how basic best practices provide a solid foundation for cybersecurity ...

The fight against malaria in Nigeria can't be won by government alone. NIMR researchers call for collective action, stressing ...

Data collected under the Death in Custody Reporting Act has some serious problems. Here’s how we fixed some of them.

Some Layer 2 networks saw their metrics crater after token distributions. Ronin (RON) experienced a 70% drop in active addresses post-airdrop. zkSync saw a 90% drop in transactions and nearly 80% ...

News » DiNAQOR and Academic Partners Launch Paradigm Shift in In Vivo Delivery of Advanced Therapies DiNAQOR and Academic Partners Launch Paradigm Shift in In Vivo Delivery of Advanced Therapies ...